Klaria Pharma Holding
0.337 SEK -9.89%1 investor is following this company
Klaria Pharma Holding operates in the pharmaceutical industry. The business is focused on developing and commercializing solutions in the therapy areas of migraine and cancer-related pain. The technology is based on the company's drug-delivery platform, where the product consists of the alginate-based polymer film. The film attaches to the patient's oral mucosa, which enables the distribution of pharmaceuticals in the body. The head office is located in Uppsala.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
KLAR
Daily low / high price
0.324 / 0.366
SEK
Market cap
43.73M SEK
Turnover
58.45K SEK
Volume
176K
Financial calendar
Interim report
2024-08-22
Interim report
2024-11-21
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Ålandsbanken | 6.7 % | 6.7 % |
Skandinaviska Enskilda Banken | 4.3 % | 4.3 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Penser Future by Carnegie: Klaria Pharma: Intervju - Marknadsuppdatering & framtidsutsikter
Redeye: Klaria Pharma Q1 - Crucial period ahead
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools